Drug study authors often fail to disclose conflicts of interest

09/11/2013 | MedPage Today (free registration)

As many as 88% of the authors of clinical trial results failed to report conflicts of interest related to the trial sponsor or a competing drugmaker, but some authors over-disclosed, Danish researchers reported at the Peer Review Congress. The researchers reviewed 100 drug trials with one or more Danish authors, who are required to disclose paid collaboration with industry. Ambiguous guidelines from the International Committee of Medical Journal Editors may be causing confusion among researchers as to what constitutes a conflict of interest, the lead researcher said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI